Filing Details

Accession Number:
0000950117-10-000372
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-23 13:00:00
Reporting Period:
2010-03-19
Filing Date:
2010-03-23
Accepted Time:
2010-03-23 16:35:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
50710 Javelin Pharmaceuticals Inc JAV Pharmaceutical Preparations (2834) 880471759
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1339402 J Martin Driscoll C/O Javelin Pharmaceuticals, Inc.
125 Cambridgepark Drive
Cambridge MA 02140
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.001 Acquisiton 2010-03-19 22,181 $1.30 236,553 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The 22,181 shares of common stock were purchased in multiple same-way open market transactions at different prices ranging from $1.29 to $1.31. The weighted average purchase price for the shares was $1.3015. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price.
  2. Includes (i) 112,505 shares of common stock, (ii) 5,000 shares of common stock purchased pursuant to the Issuer?s Employee Stock Purchase Plan and (iii) 119,048 Deferred Stock Units (DSUs) granted on May 1, 2009.